Skip to main content

Table 1 Main Indication groups for MARS® therapy

From: The Molecular Adsorbent Recirculating System (MARS®) in the intensive care unit: a rescue therapy for patients with hepatic failure

1

Acute liver failure

2

Acute decompensation on chronic liver disease

 

Complicated by progressive jaundice

 

Complicated by hepatic encephalopathy

 

Complicated by renal dysfunction

3

Intractable pruritus in cholestasis

4

Acute intoxication or overdose with substances potentially bound to albumin

5

Other indications

 

Acute hepatic failure after major hepatectomy

 

After liver transplantation

 

   Primary non-function or primary dysfunction of the graft

 

   Acute decompensation of the graft (disease recurrence...)

 

   Secondary liver failure or multi-organ failure